WO2000069925A1 - Method of producing inherently microbicidal polymer surfaces - Google Patents

Method of producing inherently microbicidal polymer surfaces Download PDF

Info

Publication number
WO2000069925A1
WO2000069925A1 PCT/EP2000/002783 EP0002783W WO0069925A1 WO 2000069925 A1 WO2000069925 A1 WO 2000069925A1 EP 0002783 W EP0002783 W EP 0002783W WO 0069925 A1 WO0069925 A1 WO 0069925A1
Authority
WO
WIPO (PCT)
Prior art keywords
film
radiation
antimicrobial
substrate
minutes
Prior art date
Application number
PCT/EP2000/002783
Other languages
German (de)
French (fr)
Inventor
Peter Ottersbach
Friedrich Sosna
Original Assignee
Creavis Gesellschaft Für Technologie Und Innovation Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creavis Gesellschaft Für Technologie Und Innovation Mbh filed Critical Creavis Gesellschaft Für Technologie Und Innovation Mbh
Priority to AU72362/00A priority Critical patent/AU7236200A/en
Priority to EP00922570A priority patent/EP1183282A1/en
Publication of WO2000069925A1 publication Critical patent/WO2000069925A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/12Chemical modification
    • C08J7/16Chemical modification with polymerisable compounds
    • C08J7/18Chemical modification with polymerisable compounds using wave energy or particle radiation
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10Macromolecular compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/04Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52Amides or imides
    • C08F220/54Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/60Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F283/00Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
    • C08F283/04Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polycarbonamides, polyesteramides or polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F291/00Macromolecular compounds obtained by polymerising monomers on to macromolecular compounds according to more than one of the groups C08F251/00 - C08F289/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents

Definitions

  • the invention relates to a process for the production of antimicrobial polymers by polymerizing amino-functionalized monomers and the use of the antimicrobial polymers thus produced
  • the invention further relates to a process for the production of antimicrobial polymers by graft polymerization of amino-functionalized monomers on a substrate and the use of the antimicrobial substrates thus produced
  • Bacteria must be kept away from all areas of life in which hygiene is important.This affects textiles for direct body contact, in particular for the genital area and for nursing and elderly care.In addition, bacteria must be kept away from furniture and device surfaces in care stations, particularly in the area of Intensive care and the care of small children, in hospitals, in particular in rooms for medical interventions and in isolation stations for critical infection cases and in toilets
  • Tert-butylaminoethyl methacrylate is a commercially available monomer of methacrylate chemistry and is used in particular as a hydrophilic component in copolymerizations.
  • EP-PS 0 290 676 describes the use of various polyacrylates and polymethacrylates as a matrix for the immobilization of bactericidal quaternary ammonium compounds
  • US Pat. No. 4,532,269 discloses a terpolymer of butyl methacrylate, tributyltin methacrylate and tert-butylaminoethyl methacrylate.
  • This polymer is used as an antimicrobial marine paint, the hydrophilic tert-butylaminoethyl methacrylate requiring the slow erosion of the polymer and thus the highly toxic tributyltin microbial methacrylate releases
  • the copolymer produced with aminomethacrylates is only a matrix or carrier substance for added microbicidal active ingredients which can diffuse or migrate from the carrier substance.
  • Polymers of this type lose their effect more or less quickly if the necessary “minimal inhibitory concentration” is found on the surface. (MIK) is no longer achieved
  • the present invention is therefore based on the object of developing novel, antimicrobial polymers which, if necessary, are intended as a coating to prevent the settling and spreading of bacteria on surfaces
  • the present invention relates to a process for the preparation of antimicrobial polymers, characterized in that aliphatically unsaturated monomers which are functionalized at least once by a primary amino group are polymerized.
  • the aliphatically unsaturated monomers functionalized at least simply by a primary amino group in the process according to the invention can have a hydrocarbon radical of up to 50, preferably up to 30, particularly preferably up to 22 carbon atoms.
  • the monomers can also be substituted by keto or aldehyde groups such as acryloyl or oxo groups or cyclic hydrocarbon groups such as substituted or unsubstituted phenyl or cyclohexyl groups.
  • the monomers used according to the invention should have a molar mass of less than 900, preferably less than 550 g / mol.
  • aliphatic unsaturated monomers of the general formula which are functionalized simply by a primary amino group are functionalized simply by a primary amino group
  • Ri branched, unbranched or cyclic, aliphatic unsaturated
  • Hydrocarbon radicals with up to 50 carbon atoms which can be substituted by O, N or S atoms, are used.
  • Suitable monomer building blocks are all aliphatic unsaturated monomers which have at least one primary amino function, such as, for example, l-amino-2-propene, N-6-aminohexyl-2- propenamide, N-3-aminopropyl methacrylamide hydrochloride, methacrylic acid-2-aminoethyl ester hydrochloride and 3-aminopropyl vinyl ether.
  • the process according to the invention can also be carried out by polymerizing the monomers which are functionalized at least once by a primary amino group on a substrate. A physisorbed coating of the antimicrobial copolymer is obtained on the substrate.
  • All polymeric plastics are suitable as substrate materials.
  • the method according to the invention can also be applied to surfaces of lacquered or otherwise plastic, metal, glass or wooden bodies.
  • the antimicrobial polymers can be obtained by graft-polymerizing a substrate with an aliphatic unsaturated monomer which is functionalized at least simply by a primary amino group.
  • the grafting of the substrate enables the antimicrobial polymer to be covalently bound to the substrate.
  • All polymeric materials, such as the plastics already mentioned, can be used as substrates.
  • the surfaces of the substrates can be modified a number of times before the graft copolymerization
  • Methods are activated. All standard methods for activating polymer surfaces can be used here; For example, the activation of the substrate before the graft polymerization by UV radiation, plasma treatment, corona treatment, flame treatment, ozonization, electrical discharge of the ⁇ radiation, methods used.
  • the surfaces are expediently removed beforehand in a known manner by means of a solvent
  • the substrates can be activated by UV radiation in the wavelength range 170-400 nm, preferably 170-250 nm.
  • a suitable radiation source is, for example, a UV excimer device HERAEUS Noblelight, Hanau, Germany.
  • mercury vapor lamps are also suitable for substrate activation if they are emit significant amounts of radiation in the areas mentioned
  • the exposure time is generally 0 1 seconds to 20 minutes, preferably 1 second to 10 minutes
  • the activation of the standard polymers with UV radiation can also be carried out with an additional photosensitizer.
  • the photosensitizer such as benzophenone
  • the substrate surface is irradiated. This can also be done with a mercury vapor lamp with exposure times of 0.1 seconds to 20 minutes, preferably 1 second up to 10 minutes
  • the activation can also be achieved by plasma treatment using an RF or microwave plasma (Hexagon, Fa Technics Plasma, 85551 Kirchheim, Germany) in air, nitrogen or argon atmosphere.
  • the exposure times are generally 2 seconds to 30 minutes, preferably 5 seconds up to 10 minutes
  • the energy input for laboratory devices is between 100 and 500 W, preferably between 200 and 300 W.
  • Corona devices SOFTAL, Hamburg, Germany
  • the exposure times in this case are generally 1 to 10 minutes, preferably 1 to 60 seconds
  • Activation by electrical discharge, electron or ⁇ -rays (e.g. from a cobalt 60 source) and ozonization enable short exposure times, which are generally 0 1 to 60 seconds
  • Flaming substrate surfaces also leads to their activation.
  • Suitable devices especially those with a barrier flame front, can be easily built or, for example, obtained from ARCOTEC, 71297 Monsheim, Germany. They can be operated with hydrocarbons or hydrogen as fuel gas In In any case, damaging overheating of the substrate must be avoided, which is easily achieved by intimate contact with a cooled metal surface on the surface of the substrate facing away from the flame side.
  • Activation by flame treatment is accordingly limited to relatively thin, flat substrates.
  • the exposure times are generally 0 1 second to 1 minute, preferably 0 5 to 2 seconds, all of which are non-luminous flames and the distances between the substrate surfaces and the outer flame front are 0 2 to 5 cm, preferably 0 5 to 2 cm
  • the substrate surfaces activated in this way are produced using known methods, such as dipping,
  • solvents Water and water-ethanol mixtures have been used as solvents, but other solvents can also be used, provided that they have sufficient bulk for the monomers and wet the substrate surfaces well.
  • Other solvents are, for example, ethanol, methanol, methyl ethyl ketone, diethyl ether, dioxane, hexane, Heptane, benzene, toluene, chloroform, dichloromethane, tetrahydrofuran and acetonitrile. Solutions with monomer contents of 1 to 10% by weight, for example about 5% by weight, have been found to be effective in practice and generally give coherent coatings covering the substrate surface in one pass with layer thicknesses that can be more than 0 1 ⁇ m
  • the graft copolymerization of the monomers applied to the activated surfaces can expediently be initiated by radiation in the short-wave segment of the visible region or in the long-wave segment of the UV region of the electromagnetic radiation.
  • radiation from a UV excimer of the wavelengths 250 to 500 nm is very suitable. preferably from 290 to 320 nm
  • mercury vapor lamps are suitable, provided they emit considerable amounts of radiation in the areas mentioned.
  • the exposure times are generally 10 seconds to 30 minutes, preferably 2 to 15 minutes
  • a graft copolymerization can also be achieved by a process which is described in the European patent application 0 872 512 and is based on a graft polymerization of swollen monomer and initiator molecules
  • further aliphatic unsaturated monomers can be used, in addition to the monomers functionalized by a primary amino group.
  • an aliphatic unsaturated monomer functionalized at least simply by a primary amino group with acrylates or methacrylates for example acrylic acid, tert-butyl methacrylate or methyl methacrylate, can be used as the monomer mixture.
  • acrylates or methacrylates for example acrylic acid, tert-butyl methacrylate or methyl methacrylate
  • Styrene, vinyl chloride, vinyl ether, acrylamides, acrylonitriles, olefins (ethylene, propylene, butylene, isobutylene), allyl compounds, vinyl ketones, vinyl acetic acid, vinyl acetate or vinyl esters can be used
  • the antimicrobial polymers made from aliphatic unsaturated monomers, which are functionalized at least simply by a primary amino group, produced by the process according to the invention show a microbicidal or antimicrobial behavior even without grafting onto a substrate surface
  • customary free-radical initiators can be added.
  • the initiators are azonitriles, alkyl peroxides, hydroperoxides, acyl peroxides, peroxoketones, peresters, peroxocarbonates, peroxodisulfate, persulfate and all customary photoinitiators such as acetophenones, ⁇ -Hydroxyketone, Dimethylketale and and use benzophenone
  • the polymerization can also be initiated thermally or, as already stated, by electromagnetic radiation, such as UV light or ⁇ -radiation
  • the present invention furthermore relates to the use of the antimicrobial polymers produced according to the invention for the production of antimicrobially active products and the products thus produced as such.
  • the products may contain or consist of modified polymer substrates according to the invention.
  • modified polymer substrates according to the invention are preferably based on polyamides, polyurethanes, polyether block amides, Polyester amides or imides, PVC, polyolefms, silicones, polysiloxanes, polymethacrylate or polyterephthalates, which have surfaces modified with the polymers produced according to the invention
  • Antimicrobial products of this type are, for example, and in particular machine parts for food processing, components of air conditioning systems, roofing, bathroom and toilet articles, cake articles, components of sanitary facilities, components of animal cages and dwellings, toys, components in water systems, food packaging, operating elements (touch panel ) of devices and contact lenses
  • the present invention also relates to the use of the polymer substrates modified on the surface with the antimicrobial polymers produced according to the invention for the production of hygiene products or medical articles.
  • hygiene products are, for example, toothbrushes, toilet seats, combs and packaging materials also other objects that may come into contact with many people, such as a telephone receiver, handrails of stairs, door and window handles, and holding straps and handles in public transport.
  • Medical technology items include catheters, tubes, cover foils, and surgical cutlery
  • copolymers or graft copolymers produced according to the invention can be used wherever bacteria-free, ie microbicidal surfaces or surfaces with non-stick properties are important.
  • examples of uses for the copolymers or graft polymers produced according to the invention are, in particular, paints, protective coatings or coatings in the following areas
  • Heat exchangers bioreactors, membranes, medical technology, contact lenses, diapers, membranes, implants, utensils, car seats, clothing (stockings, sportswear), hospital facilities, door handles, telephone receivers, public transport, animal cages, cash registers, carpets, wallpapers
  • a polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus.
  • the film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is countercurrently flowed with 20 ml of a mixture of 3 g of 3-aminopropyl vinyl ether (from Aldrich) and 97 g of methanol are coated.
  • the radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of the wavelength 308 nm.
  • the radiation is started, the exposure time is 15 minutes
  • the film is then removed and rinsed with 30 ml of methanol.
  • the film is then dried in vacuo for 12 hours at 50 ° C.
  • the film is then extracted 5 times for 6 hours at 30 ° C., then dried at 50 ° C. for 12 hours
  • a coated piece of film from Example 1 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined more detectable from Staphylococcus aureus
  • a coated piece of film from Example 1 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10 3
  • a polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus.
  • the film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of methacrylic acid-2-aminoethyl ester hydrochloride (Aldrich) and 97 g of methanol are coated.
  • the radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of 308 nm.
  • the radiation is started, the Exposure time is 15 minutes.
  • the film is then removed and unwound with 30 ml of methanol.
  • the film is then dried in vacuo at 50 ° C. for 12 hours.
  • the film is then extracted 5 times for 6 hours at 30 ° C., then at 50 ° C. 12 Hours dried
  • a coated piece of film from Example 2 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined more detectable from Staphylococcus aureus
  • a coated piece of film from Example 2 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined dropped from 10 7 to 10 ⁇
  • a polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus.
  • the film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of N-3-aminopropyl methacrylamide hydrochloride (from Polysciences Ine) and 97 g of methanol are coated.
  • the radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of the wavelength 308 nm.
  • the radiation is started, the exposure time is 15 minutes.
  • the film is then removed and unwound with 30 ml of methanol.
  • the film is then dried in vacuo for 12 hours at 50 ° C.
  • the film is then extracted 5 times for 6 hours at 30 ° C., then at 50 ° C. Dried for 12 hours
  • a coated piece of film from Example 3 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test mixture is determined more detectable from Staphylococcus aureus
  • a coated piece of film from Example 3 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10
  • a polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus.
  • the film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of 3-aminopropyl vinyl ether (from Aldrich), 2 g of methyl methacrylate (from Aldrich) and 95 g of methanol are covered.
  • the radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of the wavelength 308 nm
  • the irradiation is started, the exposure time is 15 minutes.
  • the film is then removed and unwound with 30 ml of methanol.
  • the film is then dried in vacuo at 50 ° C. for 12 hours.
  • the film is then extracted 5 times 6 hours at 30 ° C. in water. then dried at 50 ° C for 12 hours
  • a coated piece of film from example 4 (5 ⁇ 4 cm) is placed in 30 ml of a test germ suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test germ suspension is removed, and the number of germs in the test mixture is determined. After this time there are no germs more detectable from Staphylococcus aureus
  • a coated piece of film from Example 4 (5 ⁇ 4 cm) is placed in 30 ml of a test germ suspension from Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test germ suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10 4
  • a polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus.
  • the film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of methacrylic acid-2-aminoethyl ester hydrochloride (Aldrich), 2 g of methyl methacrylate (Aldrich) and 95 g of methanol are coated.
  • the radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which emits wavelength 308 nm.
  • the irradiation is started, the exposure time is 15 minutes.
  • the film is then removed and rinsed with 30 ml of methanol.
  • the film is then dried in vacuo for 12 hours at 50 ° C.
  • the film is then 5 times 6 hours at 30 ° C. in water extracted, then dried at 50 ° C for 12 hours
  • a coated piece of film from Example 5 (5 ⁇ 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined more detectable from Staphylococcus aureus
  • a coated piece of film from Example 5 (5 ⁇ 4 cm) is placed in 30 ml of a test germ suspension from Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test germ suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10 4

Abstract

The invention relates to a method of producing inherently microbicidal polymer surfaces by polymerizing aliphatically unsaturated monomers that are at least singly functionalized by a primary amine group. The antimicrobial polymers of the invention can be used as a microbicidal coating inter alia on hygiene articles or in the medical field as well as in lacquers and protective coatings.

Description

Verfahren zur Herstellung inhärent mikrobizider PolymeroberflächenProcess for the production of inherently microbicidal polymer surfaces
Die Erfindung betrifft ein Nerfahren zur Herstellung antimikrobieller Polymere durch Polymerisation von aminofunktionalisierten Monomeren und die Verwendung der so hergestellten antimikrobiellen PolymereThe invention relates to a process for the production of antimicrobial polymers by polymerizing amino-functionalized monomers and the use of the antimicrobial polymers thus produced
Desweiteren betrifft die Erfindung ein Nerfahren zur Herstellung antimikrobieller Polymere durch Pfropfpolymerisation von aminofunktionalisierten Monomeren auf einem Substrat und die Verwendung der so hergestellten antimikrobiellen SubstrateThe invention further relates to a process for the production of antimicrobial polymers by graft polymerization of amino-functionalized monomers on a substrate and the use of the antimicrobial substrates thus produced
Besiedlungen und Ausbreitungen von Bakterien auf Oberflachen von Rohrleitungen, Behaltern oder Verpackungen sind im hohen Maße unerwünscht Es bilden sich häufig Schleimschichten, die Mikrobenpopulationen extrem ansteigen lassen, die Wasser-, Getränke- und Lebensmittelqualitaten nachhaltig beeinträchtigen und sogar zum Verderben der Ware sowie zur gesundheitlichen Schädigung der Verbraucher fuhren könnenColonization and spreading of bacteria on the surfaces of pipelines, containers or packaging are highly undesirable.Mucous layers often form, which extremely increase microbial populations, which have a lasting impact on the quality of water, beverages and food, and even spoil the goods and cause health damage the consumer can drive
Aus allen Lebensbereichen, in denen Hygiene von Bedeutung ist, sind Bakterien fernzuhalten Davon betroffen sind Textilien für den direkten Korperkontakt, insbesondere für den Intimbereich und für die Kranken- und Altenpflege Außerdem sind Bakterien fernzuhalten von Möbel- und Gerateoberflachen in Pflegestationen, insbesondere im Bereich der Intensivpflege und der Kleinstkinder-Pflege, in Krankenhausern, insbesondere in Räumen für medizinische Eingriffe und in Isolierstationen für kritische Infektionsfalle sowie in ToilettenBacteria must be kept away from all areas of life in which hygiene is important.This affects textiles for direct body contact, in particular for the genital area and for nursing and elderly care.In addition, bacteria must be kept away from furniture and device surfaces in care stations, particularly in the area of Intensive care and the care of small children, in hospitals, in particular in rooms for medical interventions and in isolation stations for critical infection cases and in toilets
Gegenwartig werden Gerate, Oberflachen von Mobein und Textilien gegen Bakterien im Bedarfsfall oder auch vorsorglich mit Chemikalien oder deren Losungen sowie Mischungen behandelt, die als Desinfektionsmittel mehr oder weniger breit und massiv antimikrobiell wirken Solche chemischen Mittel wirken unspezifisch, sind häufig selbst toxisch oder reizend oder bilden gesundheitlich bedenkliche Abbauprodukte Häufig zeigen sich auchAt present devices, surfaces of mobeine and textiles against bacteria are treated if necessary or as a precautionary measure with chemicals or their solutions as well as mixtures which act as a disinfectant to a greater or lesser extent and have a massive antimicrobial effect.These chemical agents have a non-specific effect, are often themselves toxic or irritating or form degradation products that are harmful to health
Unverträglichkeiten bei entsprechend sensibilisierten PersonenIncompatibilities in appropriately sensitized people
Eine weitere Vorgehensweise gegen oberflachige Bakterienausbreitungen stellt dieAnother approach against superficial spread of bacteria is the
Einarbeitung antimikrobiell wirkender Substanzen in eine Matrix dar Tert -Butylaminoethylmethacrylat ist ein handelsübliches Monomer der Methacrylatchemie und wird insbesondere als hydrophiler Bestandteil in Copolymerisationen eingesetzt So wird in EP-PS 0 290 676 der Einsatz verschiedener Polyacrylate und Polymethacrylate als Matrix für die Immobilisierung von bakteriziden quaternaren Ammoniumverbindungen beschriebenIncorporation of antimicrobial substances into a matrix Tert-butylaminoethyl methacrylate is a commercially available monomer of methacrylate chemistry and is used in particular as a hydrophilic component in copolymerizations. EP-PS 0 290 676 describes the use of various polyacrylates and polymethacrylates as a matrix for the immobilization of bactericidal quaternary ammonium compounds
Aus einem anderen technischen Bereich offenbart US-PS 4 532 269 ein Terpolymer aus Butylmethacrylat, Tributylzinnmethacrylat und tert -Butylaminoethylmethacrylat Dieses Polymer wird als antimikrobieller Schiffsanstrich verwendet, wobei das hydrophile tert - Butylaminoethylmethacrylat die langsame Erosion des Polymers fordert und so das hochtoxische Tributylzinnmethacrylat als antimikrobiellen Wirkstoff freisetztFrom another technical field, US Pat. No. 4,532,269 discloses a terpolymer of butyl methacrylate, tributyltin methacrylate and tert-butylaminoethyl methacrylate. This polymer is used as an antimicrobial marine paint, the hydrophilic tert-butylaminoethyl methacrylate requiring the slow erosion of the polymer and thus the highly toxic tributyltin microbial methacrylate releases
In diesen Anwendungen ist das mit Aminomethacrylaten hergestellte Copolymer nur Matrix oder Trager Substanz für zugesetzte mikrobizide Wirkstoffe, die aus dem Tragerstoff diffundieren oder migrieren können Polymere dieser Art verlieren mehr oder weniger schnell ihre Wirkung, wenn an der Oberflache die notwendige „minimale inhibitorische Konzentration,, (MIK) nicht mehr erreicht wirdIn these applications, the copolymer produced with aminomethacrylates is only a matrix or carrier substance for added microbicidal active ingredients which can diffuse or migrate from the carrier substance. Polymers of this type lose their effect more or less quickly if the necessary “minimal inhibitory concentration” is found on the surface. (MIK) is no longer achieved
Aus den europaischen Patentanmeldungen 0 862 858 und 0 862 859 ist bekannt, daß Homo- und Copolymere von tert -Butylaminoethylmethacrylat, einem Methacrylsaureester mit sekundärer Aminofünktion, inhärent mikrobizide Eigenschaften besitzen Um unerwünschten Anpassungsvorgangen der mikrobiellen Lebensformen, gerade auch in Anbetracht der aus der Antibiotikaforschung bekannten Resistenzentwicklungen von Keimen, wirksam entgegenzutreten, müssen auch zukunftig Systeme auf Basis neuartiger Zusammensetzungen und verbesserter Wirksamkeit entwickelt werdenFrom European patent applications 0 862 858 and 0 862 859 it is known that homo- and copolymers of tert-butylaminoethyl methacrylate, a methacrylic acid ester with secondary amino function, have inherent microbicidal properties in order to undesirably adapt the microbial life forms, especially in view of those known from antibiotic research Resistance developments of germs to counteract effectively must also be developed in the future systems based on new compositions and improved effectiveness
Der vorliegenden Erfindung liegt daher die Aufgabe zugrunde, neuartige, antimikrobiell wirksame Polymere zu entwickeln Diese sollen ggf als Beschichtung die Ansiedelung und Verbreitung von Bakterien auf Oberflachen verhindernThe present invention is therefore based on the object of developing novel, antimicrobial polymers which, if necessary, are intended as a coating to prevent the settling and spreading of bacteria on surfaces
Es wurde nun überraschend gefunden, daß durch Polymerisation von aliphatisch ungesättigten Monomeren, die mindestens einfach durch eine primäre Aminogruppe funktionalisiert sind, Polymere mit einer Oberflache erhalten werden, die dauerhaft mikrobizid ist, durch Losemittel und physikalische Beanspruchung nicht angegriffen wird und keine Migration zeigen. Dabei ist es nicht nötig, weitere biozide Wirkstoffe einzusetzen.It has now surprisingly been found that by polymerizing aliphatic unsaturated monomers which are functionalized at least simply by a primary amino group, polymers having a surface which is permanently microbicidal are obtained by means of solvents and physical stress is not attacked and shows no migration. It is not necessary to use other biocidal agents.
Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Herstellung von antimikrobiellen Polymeren, dadurch gekennzeichnet, daß aliphatisch ungesättigte Monomere, die mindestens einfach durch eine primäre Aminogruppe funktionalisiert sind, polymerisiert werden.The present invention relates to a process for the preparation of antimicrobial polymers, characterized in that aliphatically unsaturated monomers which are functionalized at least once by a primary amino group are polymerized.
Die im erfindungsgemäßen Verfahren eingesetzten, mindestens einfach durch eine primäre Aminogruppe fünktionalisierten, aliphatisch ungesättigten Monomeren können einen Kohlenwasserstoffrest von bis zu 50, bevorzugt bis zu 30, besonders bevorzugt bis zu 22 Kohlenstoffatomen aufweisen. Weiterhin können die Monomeren auch durch Keto- oder Aldehydgruppen wie Acryloyl- oder Oxogruppen oder cyclische Kohlenwasserstoffreste wie substituierte oder unsubstituierte Phenyl-oder Cyclohexylreste substituiert sein.The aliphatically unsaturated monomers functionalized at least simply by a primary amino group in the process according to the invention can have a hydrocarbon radical of up to 50, preferably up to 30, particularly preferably up to 22 carbon atoms. Furthermore, the monomers can also be substituted by keto or aldehyde groups such as acryloyl or oxo groups or cyclic hydrocarbon groups such as substituted or unsubstituted phenyl or cyclohexyl groups.
Um eine ausreichende Polymerisationsgeschwindigkeit zu erreichen, sollten die erfindungsgemäß eingesetzten Monomeren eine Molmasse von unter 900, bevorzugt unter 550 g/mol aufweisen.In order to achieve a sufficient polymerization rate, the monomers used according to the invention should have a molar mass of less than 900, preferably less than 550 g / mol.
In einer besonderen Ausführungsform der vorliegenden Erfindung können einfach durch eine primäre Aminogruppe fünktionalisierte, aliphatische ungesättigte Monomere der allgemeinen FormelIn a particular embodiment of the present invention, aliphatic unsaturated monomers of the general formula which are functionalized simply by a primary amino group
Rι N H2 Rι NH 2
mit Ri: Verzweigter, unverzweigter oder cyclischer, aliphatisch ungesättigterwith Ri: branched, unbranched or cyclic, aliphatic unsaturated
Kohlenwasserstoffrest mit bis zu 50 C- Atomen, die durch O-, N- oder S-Atome substituiert sein können, eingesetzt werden.Hydrocarbon radicals with up to 50 carbon atoms, which can be substituted by O, N or S atoms, are used.
Als Monomerbausteine eignen sich alle aliphatisch ungesättigten Monomere, die zumindest eine primäre Aminofünktion besitzen, wie z.B. l-Amino-2-propen, N-6-Aminohexyl-2- propenamid, N-3 -Aminopropylmethacrylamid-hydrochlorid, Methacrylsäure-2-amino- ethylesterhydrochlorid und 3-Aminopropyl-vinylether.Suitable monomer building blocks are all aliphatic unsaturated monomers which have at least one primary amino function, such as, for example, l-amino-2-propene, N-6-aminohexyl-2- propenamide, N-3-aminopropyl methacrylamide hydrochloride, methacrylic acid-2-aminoethyl ester hydrochloride and 3-aminopropyl vinyl ether.
Das erfindungsgemäße Verfahren kann auch durch Polymerisation der mindestens einfach durch eine primäre Aminogruppe fünktionalisierten Monomere auf einem Substrat durchgeführt werden. Es wird eine physisorbierte Beschichtung aus dem antimikrobiellen Copolymer auf dem Substrat erhalten.The process according to the invention can also be carried out by polymerizing the monomers which are functionalized at least once by a primary amino group on a substrate. A physisorbed coating of the antimicrobial copolymer is obtained on the substrate.
Als Substratmaterialien eigenen sich vor allem alle polymeren Kunststoffe, wie z. B. Polyurethane, Polyamide, Polyester und -ether, Polyetherblockamide, Polystyrol, Polyvinylchlorid, Polycarbonate, Polyorganosiloxane, Polyolefine, Polysulfone, Polyisopren, Poly- Chloropren, Polytetrafluorethylen (PTFE), entsprechende Copolymere und Blends sowie natürliche und synthetische Kautschuke, mit oder ohne strahlungssensitive Gruppen. Das erfindungsgemäße Verfahren läßt sich auch auf Oberflächen von lackierten oder anderweitig mit Kunststoff beschichteten Metall-, Glas- oder Holzkörpern anwenden.All polymeric plastics, such as, for example, are suitable as substrate materials. B. polyurethanes, polyamides, polyesters and ethers, polyether block amides, polystyrene, polyvinyl chloride, polycarbonates, polyorganosiloxanes, polyolefins, polysulfones, polyisoprene, polychloroprene, polytetrafluoroethylene (PTFE), corresponding copolymers and blends as well as natural and synthetic rubbers, with or without radiation-sensitive Groups. The method according to the invention can also be applied to surfaces of lacquered or otherwise plastic, metal, glass or wooden bodies.
In einer weiteren Ausführungsform der vorliegenden Erfindung können die antimikrobiellen Polymere durch Pfropfpolymerisation eines Substrats mit einem mindestens einfach durch eine primäre Aminogruppe fünktionalisierten, aliphatisch ungesättigten Monomeren erhalten werden. Die Pfropfung des Substrats ermöglicht eine kovalente Anbindung des antimikrobiellen Polymers an das Substrat. Als Substrate können alle polymeren Materialien, wie die bereits genannten Kunststoffe eingesetzt werden.In a further embodiment of the present invention, the antimicrobial polymers can be obtained by graft-polymerizing a substrate with an aliphatic unsaturated monomer which is functionalized at least simply by a primary amino group. The grafting of the substrate enables the antimicrobial polymer to be covalently bound to the substrate. All polymeric materials, such as the plastics already mentioned, can be used as substrates.
Die Oberflächen der Substrate können vor der Pfropfcopolymerisation nach einer Reihe vonThe surfaces of the substrates can be modified a number of times before the graft copolymerization
Methoden aktiviert werden. Hier können alle Standardmethoden zur Aktivierung von polymeren Oberflächen zum Einsatz kommen; Beispielsweise ist die Aktivierung des Substrats vor der Pfropfpolymerisation durch UV-Strahlung, Plasmabehandlung, Coronabehandlung, Beflammung, Ozonisierung, elektrische Entladung der γ- Strahlung, eingesetzte Methoden.Methods are activated. All standard methods for activating polymer surfaces can be used here; For example, the activation of the substrate before the graft polymerization by UV radiation, plasma treatment, corona treatment, flame treatment, ozonization, electrical discharge of the γ radiation, methods used.
Zweckmäßig werden die Oberflächen zuvor in bekannter Weise mittels eines Lösemittels vonThe surfaces are expediently removed beforehand in a known manner by means of a solvent
Ölen, Fetten oder anderen Verunreinigungen befreit. Die Aktivierung der Substrate kann durch UV-Strahlung im Wellenlangenbereich 170- 400 nm, bevorzugt 170-250 nm erfolgen Eine geeignete Strahlenquelle ist z B ein UV-Excimer-Gerat HERAEUS Noblelight, Hanau, Deutschland Aber auch Quecksilberdampflampen eignen sich zur Substrataktivierung, sofern sie erhebliche Strahlungsanteile in den genannten Bereichen emittieren Die Expositionszeit betragt im allgemeinen 0 1 Sekunden bis 20 Minuten, vorzugsweise 1 Sekunde bis 10 MinutenFree from oils, greases or other contaminants. The substrates can be activated by UV radiation in the wavelength range 170-400 nm, preferably 170-250 nm. A suitable radiation source is, for example, a UV excimer device HERAEUS Noblelight, Hanau, Germany. However, mercury vapor lamps are also suitable for substrate activation if they are emit significant amounts of radiation in the areas mentioned The exposure time is generally 0 1 seconds to 20 minutes, preferably 1 second to 10 minutes
Die Aktivierung der Standardpolymeren mit UV-Strahlung kann weiterhin mit einem zusatzlichen Photo sensibilisator erfolgen Hierzu wird der Photosensibilisator, wie z B Benzophenon auf die Substratoberflache aufgebracht und bestrahlt Dies kann ebenfalls mit einer Quecksilberdampflampe mit Expositionszeiten von 0 1 Sekunden bis 20 Minuten, vorzugsweise 1 Sekunde bis 10 Minuten, erfolgenThe activation of the standard polymers with UV radiation can also be carried out with an additional photosensitizer. For this purpose, the photosensitizer, such as benzophenone, is applied to the substrate surface and irradiated. This can also be done with a mercury vapor lamp with exposure times of 0.1 seconds to 20 minutes, preferably 1 second up to 10 minutes
Die Aktivierung kann erfindungsgemaß auch durch Plasmabehandlung mittels eines RF- oder Mikrowellenplasma (Hexagon, Fa Technics Plasma, 85551 Kirchheim, Deutschland) in Luft, Stickstoff- oder Argon-Atmosphare erreicht werden Die Expositionszeiten betragen im allgemeinen 2 Sekunden bis 30 Minuten, vorzugsweise 5 Sekunden bis 10 Minuten Der Energieeintrag liegt bei Laborgeraten zwischen 100 und 500 W, vorzugsweise zwischen 200 und 300 WAccording to the invention, the activation can also be achieved by plasma treatment using an RF or microwave plasma (Hexagon, Fa Technics Plasma, 85551 Kirchheim, Germany) in air, nitrogen or argon atmosphere. The exposure times are generally 2 seconds to 30 minutes, preferably 5 seconds up to 10 minutes The energy input for laboratory devices is between 100 and 500 W, preferably between 200 and 300 W.
Weiterhin lassen sich auch Corona-Gerate (Fa SOFTAL, Hamburg, Deutschland) zur Aktivierung verwenden Die Expositionszeiten betragen in diesem Falle in der Regel 1 bis 10 Minuten, vorzugsweise 1 bis 60 SekundenCorona devices (SOFTAL, Hamburg, Germany) can also be used for activation. The exposure times in this case are generally 1 to 10 minutes, preferably 1 to 60 seconds
Die Aktivierung durch elektrische Entladung, Elektronen- oder γ-Strahlen (z B aus einer Kobalt-60-Quelle) sowie die Ozonisierung ermöglicht kurze Expositionszeiten, die im allgemeinen 0 1 bis 60 Sekunden betragenActivation by electrical discharge, electron or γ-rays (e.g. from a cobalt 60 source) and ozonization enable short exposure times, which are generally 0 1 to 60 seconds
Eine Beflammung von Substrat-Oberflachen führt ebenfalls zu deren Aktivierung Geeignete Gerate, insbesondere solche mit einer Barriere-Flammfront, lassen sich auf einfache Weise bauen oder beispielsweise beziehen von der Fa ARCOTEC, 71297 Monsheim, Deutschland Sie können mit Kohlenwasserstoffen oder Wasserstoff als Brenngas betrieben werden In jedem Fall muß eine schädliche Uberhitzung des Substrats vermieden werden, was durch innigen Kontakt mit einer gekühlten Metallflache auf der von der Beflammungsseite abgewandten Substratoberflache leicht erreicht wird Die Aktivierung durch Beflammung ist dementsprechend auf verhältnismäßig dünne, flachige Substrate beschrankt Die Expositionszeiten belaufen sich im allgemeinen auf 0 1 Sekunde bis 1 Minute, vorzugsweise 0 5 bis 2 Sekunden, wobei es sich ausnahmslos um nicht leuchtende Flammen behandelt und die Abstände der Substratoberflachen zur äußeren Flammenfront 0 2 bis 5 cm, vorzugsweise 0 5 bis 2 cm betragenFlaming substrate surfaces also leads to their activation. Suitable devices, especially those with a barrier flame front, can be easily built or, for example, obtained from ARCOTEC, 71297 Monsheim, Germany. They can be operated with hydrocarbons or hydrogen as fuel gas In In any case, damaging overheating of the substrate must be avoided, which is easily achieved by intimate contact with a cooled metal surface on the surface of the substrate facing away from the flame side.Activation by flame treatment is accordingly limited to relatively thin, flat substrates.The exposure times are generally 0 1 second to 1 minute, preferably 0 5 to 2 seconds, all of which are non-luminous flames and the distances between the substrate surfaces and the outer flame front are 0 2 to 5 cm, preferably 0 5 to 2 cm
Die so aktivierten Substratoberflachen werden nach bekannten Methoden, wie Tauchen,The substrate surfaces activated in this way are produced using known methods, such as dipping,
Sprühen oder Streichen, mit aliphatisch ungesättigten Monomeren, die mindestens einfach durch eine primäre Aminogruppe funktionalisiert sind, gegebenenfalls in Losung, beschichtetSpraying or brushing, coated with aliphatic unsaturated monomers which are at least simply functionalized by a primary amino group, optionally in solution
Als Losemittel haben sich Wasser und Wasser-Ethanol-Gemische bewahrt, doch sind auch andere Losemittel verwendbar, sofern sie ein ausreichendes Losevermogen für die Monomeren aufweisen und die Substratoberflachen gut benetzen Weitere Losungsmittel sind beispielsweise Ethanol, Methanol, Methylethylketon, Diethylether, Dioxan, Hexan, Heptan, Benzol, Toluol, Chloroform, Dichlormethan, Tetrahydrofüran und Acetonitril Losungen mit Monomerengehalten von 1 bis 10 Gew -%, beispielsweise mit etwa 5 Gew -% haben sich in der Praxis bewahrt und ergeben im allgemeinen in einem Durchgang zusammenhangende, die Substratoberflache bedeckende Beschichtungen mit Schichtdicken, die mehr als 0 1 μm betragen könnenWater and water-ethanol mixtures have been used as solvents, but other solvents can also be used, provided that they have sufficient bulk for the monomers and wet the substrate surfaces well. Other solvents are, for example, ethanol, methanol, methyl ethyl ketone, diethyl ether, dioxane, hexane, Heptane, benzene, toluene, chloroform, dichloromethane, tetrahydrofuran and acetonitrile. Solutions with monomer contents of 1 to 10% by weight, for example about 5% by weight, have been found to be effective in practice and generally give coherent coatings covering the substrate surface in one pass with layer thicknesses that can be more than 0 1 μm
Die Propfcopolymerisation der auf die aktivierten Oberflachen aufgebrachten Monomeren kann zweckmäßig durch Strahlen im kurzwelligen Segment des sichtbaren Bereiches oder im langwelligen Segment des UV-Bereiches der elektromagnetischen Strahlung initiiert werden Gut geeignet ist z B die Strahlung eines UV-Excimers der Wellenlangen 250 bis 500 nm, vorzugsweise von 290 bis 320 nm Auch hier sind Quecksilberdampflampen geeignet, sofern sie erhebliche Strahlungsanteile in den genannten Bereichen emittieren Die Expositionszeiten betragen im allgemeinen 10 Sekunden bis 30 Minuten, vorzugsweise 2 bis 15 Minuten Weiterhin laßt sich eine Pfropfcopolymerisation auch durch ein Verfahren erreichen, das in der europaischen Patentanmeldung 0 872 512 beschrieben ist, und auf einer Pfropfpolymerisation von eingequollenen Monomer- und Initiatormolekulen beruhtThe graft copolymerization of the monomers applied to the activated surfaces can expediently be initiated by radiation in the short-wave segment of the visible region or in the long-wave segment of the UV region of the electromagnetic radiation. For example, radiation from a UV excimer of the wavelengths 250 to 500 nm is very suitable. preferably from 290 to 320 nm Here too, mercury vapor lamps are suitable, provided they emit considerable amounts of radiation in the areas mentioned. The exposure times are generally 10 seconds to 30 minutes, preferably 2 to 15 minutes Furthermore, a graft copolymerization can also be achieved by a process which is described in the European patent application 0 872 512 and is based on a graft polymerization of swollen monomer and initiator molecules
Im erfindungsgemaßen Verfahren können weitere aliphatisch ungesättigte Monomere, neben den durch eine primäre Aminogruppe fünktionalisierten Monomeren, verwendet werden So kann als Monomerenmischung ein mindestens einfach durch eine primäre Aminogruppe fünktionalisiertes aliphatisch ungesättigtes Monomer mit Acrylaten oder Methacrylaten, z B Acrylsaure, tert -Butylmethacrylat oder Methylmethacrylat, Styrol, Vinylchlorid, Vinylether, Acrylamide, Acrylnitrile, Olefine (Ethylen, Propylen, Butylen, Isobutylen), Allylverbindungen, Vinylketone, Vinylessigsaure, Vinylacetat oder Vinylester eingesetzt werdenIn the process according to the invention, further aliphatic unsaturated monomers can be used, in addition to the monomers functionalized by a primary amino group. Thus, an aliphatic unsaturated monomer functionalized at least simply by a primary amino group with acrylates or methacrylates, for example acrylic acid, tert-butyl methacrylate or methyl methacrylate, can be used as the monomer mixture. Styrene, vinyl chloride, vinyl ether, acrylamides, acrylonitriles, olefins (ethylene, propylene, butylene, isobutylene), allyl compounds, vinyl ketones, vinyl acetic acid, vinyl acetate or vinyl esters can be used
Die nach den erfindungsgemaßen Verfahren hergestellten antimikrobiellen Polymere aus aliphatisch ungesättigten Monomeren, die mindestens einfach durch eine primäre Aminogruppe funktionalisiert sind, zeigen auch ohne Pfropfung auf eine Substratoberflache ein mikrobizides oder antimikrobielles VerhaltenThe antimicrobial polymers made from aliphatic unsaturated monomers, which are functionalized at least simply by a primary amino group, produced by the process according to the invention show a microbicidal or antimicrobial behavior even without grafting onto a substrate surface
Wird das erfindungsgemaße Verfahren ohne Pfropfung direkt auf der Substratoberflache angewendet, so können übliche Radikalinitiatoren zugesetzt werden Als Initiatoren lassen sich u a Azonitrile, Alkylperoxide, Hydroperoxide, Acylperoxide, Peroxoketone, Perester, Peroxocarbonate, Peroxodisulfat, Persulfat und alle üblichen Photoinitiatoren wie z B Acetophenone, α-Hydroxyketone, Dimethylketale und und Benzophenon verwenden Die Polymerisationsinitiierung kann weiterhin auch thermisch oder wie bereits ausgeführt, durch elektromagnetische Strahlung, wie z B UV-Licht oder γ- Strahlung erfolgenIf the process according to the invention is used directly on the substrate surface without grafting, customary free-radical initiators can be added. Among the initiators are azonitriles, alkyl peroxides, hydroperoxides, acyl peroxides, peroxoketones, peresters, peroxocarbonates, peroxodisulfate, persulfate and all customary photoinitiators such as acetophenones, α -Hydroxyketone, Dimethylketale and and use benzophenone The polymerization can also be initiated thermally or, as already stated, by electromagnetic radiation, such as UV light or γ-radiation
Verwendung der modifizierten PolymersubstrateUse of the modified polymer substrates
Weitere Gegenstande der vorliegenden Erfindung sind die Verwendung der erfindungsgemaß hergestellten antimikrobiellen Polymere zur Herstellung von antimikrobiell wirksamen Erzeugnissen und die so hergestellten Erzeugnisse als solche Die Erzeugnisse können erfindungsgemaß modifizierte Polymersubstrate enthalten oder aus diesen bestehen Solche Erzeugnisse basieren vorzugsweise auf Polyamiden, Polyurethanen, Polyetherblockamiden, Polyesteramiden oder -imiden, PVC, Polyolefmen, Silikonen, Polysiloxanen, Polymethacrylat oder Polyterephthalaten, die mit erfindungsgemaß hergestellten Polymeren modifizierte Oberflachen aufweisenThe present invention furthermore relates to the use of the antimicrobial polymers produced according to the invention for the production of antimicrobially active products and the products thus produced as such. The products may contain or consist of modified polymer substrates according to the invention. Such products are preferably based on polyamides, polyurethanes, polyether block amides, Polyester amides or imides, PVC, polyolefms, silicones, polysiloxanes, polymethacrylate or polyterephthalates, which have surfaces modified with the polymers produced according to the invention
Antimikrobiell wirksame Erzeugnisse dieser Art sind beispielsweise und insbesondere Maschinenteile für die Lebensmittelverarbeitung, Bauteile von Klimaanlagen, Bedachungen, Badezimmer- und Toilettenartikel, Kuchenartikel, Komponenten von Sanitareinrichtungen, Komponenten von Tierkafigen - und behausungen, Spielwaren, Komponenten in Wassersystemen, Lebensmittelverpackungen, Bedienelemente (Touch Panel) von Geraten und KontaktlinsenAntimicrobial products of this type are, for example, and in particular machine parts for food processing, components of air conditioning systems, roofing, bathroom and toilet articles, cake articles, components of sanitary facilities, components of animal cages and dwellings, toys, components in water systems, food packaging, operating elements (touch panel ) of devices and contact lenses
Außerdem sind Gegenstande der vorliegenden Erfindung die Verwendung der mit erfindungsgemaß hergestellten antimikrobiellen Polymeren an der Oberflache modifizierten Polymersubstrate zur Herstellung von Hygieneerzeugnissen oder medizintechnischen Artikeln Die obigen Ausführungen über bevorzugte Materialien gelten entsprechend Solche Hygieneerzeugnisse sind beispielsweise Zahnbürsten, Toilettensitze, Kamme und Verpackungsmaterialien Unter die Bezeichnung Hygieneartikel fallen auch andere Gegenstande, die u U mit vielen Menschen in Berührung kommen, wie Telefonhorer, Handlaufe von Treppen, Tur- und Fenstergriffe sowie Haltegurte und -griffe in öffentlichen Verkehrsmitteln Medizintechnische Artikeln sind z B Katheter, Schlauche, Abdeckfolien oder auch chirurgische BesteckeThe present invention also relates to the use of the polymer substrates modified on the surface with the antimicrobial polymers produced according to the invention for the production of hygiene products or medical articles. The above statements regarding preferred materials apply accordingly. Such hygiene products are, for example, toothbrushes, toilet seats, combs and packaging materials also other objects that may come into contact with many people, such as a telephone receiver, handrails of stairs, door and window handles, and holding straps and handles in public transport. Medical technology items include catheters, tubes, cover foils, and surgical cutlery
Die erfindungsgemaß hergestellten Copolymere oder Pfropfcopolymere können überall verwendet werden, wo es auf möglichst bakterienfreie d h mikrobizide Oberflachen oder Oberflachen mit Antihafteigenschaften ankommt Verwendungsbeispiele für die erfindungsgemaß hergestellten Copolymeren oder Pfropfpolymere sind insbesondere Lacke, Schutzanstriche oder Beschichtungen in den folgenden BereichenThe copolymers or graft copolymers produced according to the invention can be used wherever bacteria-free, ie microbicidal surfaces or surfaces with non-stick properties are important. Examples of uses for the copolymers or graft polymers produced according to the invention are, in particular, paints, protective coatings or coatings in the following areas
Marine Schiffsrumpfe, Hafenanlagen, Bojen, Bohrplattformen, Ballastwassertanks - Haus Bedachungen, Keller, Wände, Fassaden, Gewächshäuser, Sonnenschutz,Marine hull, port facilities, buoys, drilling platforms, ballast water tanks - house roofing, cellars, walls, facades, greenhouses, sun protection,
Gartenzaune, Holzschutz Sanitär Öffentliche Toiletten, Badezimmer, Duschvorhange, Toilettenartikel, Schwimmbad, Sauna, Fugen, DichtmassenGarden fence, wood protection Sanitary Public toilets, bathrooms, shower curtains, toiletries, swimming pools, saunas, joints, sealing compounds
Lebensmittel Maschinen, Küche, Kuchenartikel, Schwämme, Spielwaren, Lebensmittelverpackungen, Milchverarbeitung, Trinkwassersysteme, Kosmetik - Maschinenteile Klimaanlagen, Ionentauscher, Brauchwasser, Solaranlagen,Food machines, kitchen, cake items, sponges, toys, food packaging, milk processing, drinking water systems, cosmetics - machine parts air conditioning, ion exchangers, process water, solar systems,
Wärmetauscher, Bioreaktoren, Membranen Medizintechnik Kontaktlinsen, Windeln, Membranen, Implantate Gebrauchsgegenstande Autositze, Kleidung (Strumpfe, Sportbekleidung) Krankenhauseinrichtungen, Türgriffe, Telefonhorer, Öffentliche Verkehrsmittel, Tierkafige, Registrierkassen, Teppichboden, TapetenHeat exchangers, bioreactors, membranes, medical technology, contact lenses, diapers, membranes, implants, utensils, car seats, clothing (stockings, sportswear), hospital facilities, door handles, telephone receivers, public transport, animal cages, cash registers, carpets, wallpapers
Zur weiteren Beschreibung der vorliegenden Erfindung werden die folgenden Beispiele gegeben, die die Erfindung weiter erläutern, nicht aber ihren Umfang begrenzen sollen, wie er in den Patentansprüchen dargelegt istTo further describe the present invention, the following examples are given, which further illustrate the invention but are not intended to limit its scope as set out in the claims
Beispiel 1example 1
Eine Polyamid 12-Folie wird 2 Minuten bei einem Druck von 1 mbar der 172 nm-Strahlung einer Excimerstrahlungsquelle der Fa Heraeus ausgesetzt Die so aktivierte Folie wird unter Schutzgas in einen Bestrahlungsreaktor gelegt und fixiert Daraufhin wird die Folie im Schutzgasgegenstrom mit 20 ml einer Mischung von 3 g 3-Aminopropyl-vinylether (Fa Aldrich) und 97 g Methanol uberschichtet Die Bestrahlungskammer wird verschlossen und im Abstand von 10 cm unter eine Excimerbestrahlungseinheit der Fa Heraeus gestellt, die eine Emission der Wellenlange 308 nm aufweist Die Bestrahlung wird gestartet, die Belichtungsdauer betragt 15 Minuten Die Folie wird anschließend entnommen und mit 30 ml Methanol abgespult Die Folie wird dann 12 Stunden bei 50° C im Vakuum getrocknet Anschließend wird die Folie in Wasser 5 mal 6 Stunden bei 30° C extrahiert, dann bei 50° C 12 Stunden getrocknetA polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus. The film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is countercurrently flowed with 20 ml of a mixture of 3 g of 3-aminopropyl vinyl ether (from Aldrich) and 97 g of methanol are coated. The radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of the wavelength 308 nm. The radiation is started, the exposure time is 15 minutes The film is then removed and rinsed with 30 ml of methanol. The film is then dried in vacuo for 12 hours at 50 ° C. The film is then extracted 5 times for 6 hours at 30 ° C., then dried at 50 ° C. for 12 hours
Im Anschluß wird die Ruckseite der Folie in gleicher Weise behandelt, so daß man abschließend eine beidseitig mit gepfropftem Polymer beschichtete Polyamidfolie erhalt Beispiel laThe back of the film is then treated in the same way, so that finally a polyamide film coated on both sides with grafted polymer is obtained Example la
Eine beschichtetes Folienstuck aus Beispiel 1 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Staphylococcus aureus eingelegt und geschüttelt Nach einer Kontaktzeit von 15 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit sind keine Keime von Staphylococcus aureus mehr nachweisbarA coated piece of film from Example 1 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined more detectable from Staphylococcus aureus
Beispiel lbExample lb
Eine beschichtetes Folienstuck aus Beispiel 1 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Pseudomonas aeruginosa eingelegt und geschüttelt Nach einer Kontaktzeit von 60 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit ist die Keimzahl von 107 auf 103 abgefallenA coated piece of film from Example 1 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10 3
Beispiel 2Example 2
Eine Polyamid 12-Folie wird 2 Minuten bei einem Druck von 1 mbar der 172 nm-Strahlung einer Excimerstrahlungsquelle der Fa Heraeus ausgesetzt Die so aktivierte Folie wird unter Schutzgas in einen Bestrahlungsreaktor gelegt und fixiert Daraufhin wird die Folie im Schutzgasgegenstrom mit 20 ml einer Mischung auf 3 g Methacrylsaure-2-aminoethylester- hydrochlorid (Fa Aldrich) und 97 g Methanol uberschichtet Die Bestrahlungskammer wird verschlossen und im Abstand von 10 cm unter eine Excimerbestrahlungseinheit der Fa Heraeus gestellt, die eine Emission der Wellenlange 308 nm aufweist Die Bestrahlung wird gestartet, die Belichtungsdauer betragt 15 Minuten Die Folie wird anschließend entnommen und mit 30 ml Methanol abgespult Die Folie wird dann 12 Stunden bei 50° C im Vakuum getrocknet Anschließend wird die Folie in Wasser 5 mal 6 Stunden bei 30° C extrahiert, dann bei 50° C 12 Stunden getrocknetA polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus. The film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of methacrylic acid-2-aminoethyl ester hydrochloride (Aldrich) and 97 g of methanol are coated. The radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of 308 nm. The radiation is started, the Exposure time is 15 minutes. The film is then removed and unwound with 30 ml of methanol. The film is then dried in vacuo at 50 ° C. for 12 hours. The film is then extracted 5 times for 6 hours at 30 ° C., then at 50 ° C. 12 Hours dried
Im Anschluß wird die Ruckseite der Folie in gleicher Weise behandelt, so daß man abschließend eine beidseitig mit gepfropftem Polymer beschichtete Polyamidfolie erhalt Beispiel 2aThe back of the film is then treated in the same way, so that finally a polyamide film coated on both sides with grafted polymer is obtained Example 2a
Eine beschichtetes Folienstuck aus Beispiel 2 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Staphylococcus aureus eingelegt und geschüttelt Nach einer Kontaktzeit von 15 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit sind keine Keime von Staphylococcus aureus mehr nachweisbarA coated piece of film from Example 2 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined more detectable from Staphylococcus aureus
Beispiel 2bExample 2b
Eine beschichtetes Folienstuck aus Beispiel 2 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Pseudomonas aeruginosa eingelegt und geschüttelt Nach einer Kontaktzeit von 60 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit ist die Keimzahl von 107 auf 10^ abgefallenA coated piece of film from Example 2 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined dropped from 10 7 to 10 ^
Beispiel 3Example 3
Eine Polyamid 12-Folie wird 2 Minuten bei einem Druck von 1 mbar der 172 nm-Strahlung einer Excimerstrahlungsquelle der Fa Heraeus ausgesetzt Die so aktivierte Folie wird unter Schutzgas in einen Bestrahlungsreaktor gelegt und fixiert Daraufhin wird die Folie im Schutzgasgegenstrom mit 20 ml einer Mischung auf 3 g N-3-Aminopropylmethacrylamid- hydrochlorid (Fa Polysciences Ine ) und 97 g Methanol uberschichtet Die Bestrahlungskammer wird verschlossen und im Abstand von 10 cm unter eine Excimerbestrahlungseinheit der Fa Heraeus gestellt, die eine Emission der Wellenlange 308 nm aufweist Die Bestrahlung wird gestartet, die Belichtungsdauer betragt 15 Minuten Die Folie wird anschließend entnommen und mit 30 ml Methanol abgespult Die Folie wird dann 12 Stunden bei 50° C im Vakuum getrocknet Anschließend wird die Folie in Wasser 5 mal 6 Stunden bei 30° C extrahiert, dann bei 50° C 12 Stunden getrocknetA polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus. The film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of N-3-aminopropyl methacrylamide hydrochloride (from Polysciences Ine) and 97 g of methanol are coated. The radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of the wavelength 308 nm. The radiation is started, the exposure time is 15 minutes. The film is then removed and unwound with 30 ml of methanol. The film is then dried in vacuo for 12 hours at 50 ° C. The film is then extracted 5 times for 6 hours at 30 ° C., then at 50 ° C. Dried for 12 hours
Im Anschluß wird die Ruckseite der Folie in gleicher Weise behandelt, so daß man abschließend eine beidseitig mit gepfropftem Polymer beschichtete Polyamidfolie erhalt Beispiel 3 aThe back of the film is then treated in the same way, so that finally a polyamide film coated on both sides with grafted polymer is obtained Example 3 a
Eine beschichtetes Folienstuck aus Beispiel 3 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Staphylococcus aureus eingelegt und geschüttelt Nach einer Kontaktzeit von 15 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit sind keine Keime von Staphylococcus aureus mehr nachweisbarA coated piece of film from Example 3 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test mixture is determined more detectable from Staphylococcus aureus
Beispiel 3bExample 3b
Eine beschichtetes Folienstuck aus Beispiel 3 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Pseudomonas aeruginosa eingelegt und geschüttelt Nach einer Kontaktzeit von 60 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit ist die Keimzahl von 107 auf 10 abgefallenA coated piece of film from Example 3 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10
Beispiel 4Example 4
Eine Polyamid 12-Folie wird 2 Minuten bei einem Druck von 1 mbar der 172 nm-Strahlung einer Excimerstrahlungsquelle der Fa Heraeus ausgesetzt Die so aktivierte Folie wird unter Schutzgas in einen Bestrahlungsreaktor gelegt und fixiert Daraufhin wird die Folie im Schutzgasgegenstrom mit 20 ml einer Mischung auf 3 g 3-Aminopropyl-vinylether (Fa Aldrich), 2 g Methylmethacrylat (Fa Aldrich) und 95 g Methanol uberschichtet Die Bestrahlungskammer wird verschlossen und im Abstand von 10 cm unter eine Excimerbestrahlungseinheit der Fa Heraeus gestellt, die eine Emission der Wellenlange 308 nm aufweist Die Bestrahlung wird gestartet, die Belichtungsdauer betragt 15 Minuten Die Folie wird anschließend entnommen und mit 30 ml Methanol abgespult Die Folie wird dann 12 Stunden bei 50° C im Vakuum getrocknet Anschließend wird die Folie in Wasser 5 mal 6 Stunden bei 30° C extrahiert, dann bei 50° C 12 Stunden getrocknetA polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus. The film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of 3-aminopropyl vinyl ether (from Aldrich), 2 g of methyl methacrylate (from Aldrich) and 95 g of methanol are covered. The radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which has an emission of the wavelength 308 nm The irradiation is started, the exposure time is 15 minutes. The film is then removed and unwound with 30 ml of methanol. The film is then dried in vacuo at 50 ° C. for 12 hours. The film is then extracted 5 times 6 hours at 30 ° C. in water. then dried at 50 ° C for 12 hours
Im Anschluß wird die Ruckseite der Folie in gleicher Weise behandelt, so daß man abschließend eine beidseitig mit gepfropftem Polymer beschichtete Polyamidfolie erhalt Beispiel 4aThe back of the film is then treated in the same way, so that finally a polyamide film coated on both sides with grafted polymer is obtained Example 4a
Eine beschichtetes Folienstuck aus Beispiel 4 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Staphylococcus aureus eingelegt und geschüttelt Nach einer Kontaktzeit von 15 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit sind keine Keime von Staphylococcus aureus mehr nachweisbarA coated piece of film from example 4 (5 × 4 cm) is placed in 30 ml of a test germ suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test germ suspension is removed, and the number of germs in the test mixture is determined. After this time there are no germs more detectable from Staphylococcus aureus
Beispiel 4bExample 4b
Eine beschichtetes Folienstuck aus Beispiel 4 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Pseudomonas aeruginosa eingelegt und geschüttelt Nach einer Kontaktzeit von 60 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit ist die Keimzahl von 107 auf 104 abgefallenA coated piece of film from Example 4 (5 × 4 cm) is placed in 30 ml of a test germ suspension from Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test germ suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10 4
Beispiel 5Example 5
Eine Polyamid 12-Folie wird 2 Minuten bei einem Druck von 1 mbar der 172 nm-Strahlung einer Excimerstrahlungsquelle der Fa Heraeus ausgesetzt Die so aktivierte Folie wird unter Schutzgas in einen Bestrahlungsreaktor gelegt und fixiert Daraufhin wird die Folie im Schutzgasgegenstrom mit 20 ml einer Mischung auf 3 g Methacrylsaure-2-aminoethylester- hydrochlorid (Fa Aldrich), 2 g Methylmethacrylat (Fa Aldrich) und 95 g Methanol uberschichtet Die Bestrahlungskammer wird verschlossen und im Abstand von 10 cm unter eine Excimerbestrahlungseinheit der Fa Heraeus gestellt, die eine Emission der Wellenlange 308 nm aufweist Die Bestrahlung wird gestartet, die Belichtungsdauer betragt 15 Minuten Die Folie wird anschließend entnommen und mit 30 ml Methanol abgespult Die Folie wird dann 12 Stunden bei 50° C im Vakuum getrocknet Anschließend wird die Folie in Wasser 5 mal 6 Stunden bei 30° C extrahiert, dann bei 50° C 12 Stunden getrocknetA polyamide 12 film is exposed for 2 minutes at a pressure of 1 mbar to 172 nm radiation from an excimer radiation source from Heraeus. The film activated in this way is placed in an irradiation reactor under protective gas and fixed thereupon the film is exposed to 20 ml of a mixture in a protective gas countercurrent 3 g of methacrylic acid-2-aminoethyl ester hydrochloride (Aldrich), 2 g of methyl methacrylate (Aldrich) and 95 g of methanol are coated. The radiation chamber is closed and placed at a distance of 10 cm under an excimer radiation unit from Heraeus, which emits wavelength 308 nm. The irradiation is started, the exposure time is 15 minutes. The film is then removed and rinsed with 30 ml of methanol. The film is then dried in vacuo for 12 hours at 50 ° C. The film is then 5 times 6 hours at 30 ° C. in water extracted, then dried at 50 ° C for 12 hours
Im Anschluß wird die Ruckseite der Folie in gleicher Weise behandelt, so daß man abschließend eine beidseitig mit gepfropftem Polymer beschichtete Polyamidfolie erhalt Beispiel 5aThe back of the film is then treated in the same way, so that finally a polyamide film coated on both sides with grafted polymer is obtained Example 5a
Eine beschichtetes Folienstuck aus Beispiel 5 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Staphylococcus aureus eingelegt und geschüttelt Nach einer Kontaktzeit von 15 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit sind keine Keime von Staphylococcus aureus mehr nachweisbarA coated piece of film from Example 5 (5 × 4 cm) is placed in 30 ml of a test microbial suspension of Staphylococcus aureus and shaken. After a contact time of 15 minutes, 1 ml of the test microbial suspension is removed, and the number of bacteria in the test batch is determined more detectable from Staphylococcus aureus
Beispiel 5bExample 5b
Eine beschichtetes Folienstuck aus Beispiel 5 (5 mal 4 cm) wird in 30 ml einer Testkeimsuspension von Pseudomonas aeruginosa eingelegt und geschüttelt Nach einer Kontaktzeit von 60 Minuten wird 1 ml der Testkeimsuspension entnommen, und die Keimzahl im Versuchsansatz bestimmt Nach Ablauf dieser Zeit ist die Keimzahl von 107 auf 104 abgefallenA coated piece of film from Example 5 (5 × 4 cm) is placed in 30 ml of a test germ suspension from Pseudomonas aeruginosa and shaken. After a contact time of 60 minutes, 1 ml of the test germ suspension is removed, and the number of bacteria in the test mixture is determined dropped from 10 7 to 10 4
Zusatzlich zur oben beschriebenen mikrobiziden Wirksamkeit gegenüber Zellen von Pseudomonas aeruginosa und Staphylococcus aureus zeigten alle Proben ebenfalls eine mikrobizide Wirkung gegenüber Zellen von Klebsieila pneumoniae, Escherichia coli, Rhizopus oryzae, Candida tropicalis und Tetrahymena pyriformis In addition to the microbicidal activity against cells from Pseudomonas aeruginosa and Staphylococcus aureus described above, all samples also showed a microbicidal activity against cells from Klebsieila pneumoniae, Escherichia coli, Rhizopus oryzae, Candida tropicalis and Tetrahymena pyriformis

Claims

Patentansprüche: Claims:
1. Verfahren zur Herstellung von antimikrobiellen Polymeren, dadurch gekennzeichnet, daß aliphatisch ungesättigte Monomere, die mindestens einfach durch eine primäre1. A process for the preparation of antimicrobial polymers, characterized in that aliphatic unsaturated monomers which are at least simple by a primary
Aminogruppe funktionalisiert sind, polymerisiert werden.Amino group are functionalized, polymerized.
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß durch eine primäre Aminogruppe fünktionalisierte aliphatische ungesättigte2. The method according to claim 1, characterized in that functionalized by a primary amino group aliphatic unsaturated
Monomere der allgemeinen FormelMonomers of the general formula
Figure imgf000017_0001
Figure imgf000017_0001
mit Ri: Verzweigter, unverzweigter oder cyclischer, aliphatisch ungesättigterwith Ri: branched, unbranched or cyclic, aliphatic unsaturated
Kohlenwasserstoffrest mit bis zu 50 C- Atomen, die durch O-, N- oder S-Atome substituiert sein könnenHydrocarbon residue with up to 50 carbon atoms, which can be substituted by O, N or S atoms
eingesetzt werden.be used.
3. Verfahren nach Anspruch 1 oder 2, dadurch gekennzeichnet daß die Polymerisation mit weiteren, aliphatisch ungesättigten Monomeren durchgeführt wird.3. The method according to claim 1 or 2, characterized in that the polymerization is carried out with further, aliphatic unsaturated monomers.
4. Verfahren nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, daß die Polymerisation auf einem Substrat durchgeführt wird.4. The method according to any one of claims 1 to 3, characterized in that the polymerization is carried out on a substrate.
5. Verfahren nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, daß die Polymerisation als Pfropfpolymerisation eines Substrats durchgeführt wird.5. The method according to any one of claims 1 to 4, characterized in that the polymerization is carried out as a graft polymerization of a substrate.
6. Verfahren nach Anspruch 5, dadurch gekennzeichnet, daß das Substrat vor der Pfropfpolymerisation durch UV-Strahlung, Plasmabehandlung,6. The method according to claim 5, characterized in that the substrate before the graft polymerization by UV radiation, plasma treatment,
Koronabehandlung, Beflammung, Ozonisierung, elektrische Entladung oder γ-Strahlung aktiviert wird.Corona treatment, flame treatment, ozonization, electrical discharge or γ-radiation is activated.
7. Verfahren nach Anspruch 5, dadurch gekennzeichnet, daß das Substrat vor der Pfropfpolymerisation durch UV-Strahlung mit einem Photosensibilisator aktiviert wird.7. The method according to claim 5, characterized in that the substrate is activated before the graft polymerization by UV radiation with a photosensitizer.
8. Verwendung der nach einem der Ansprüche 1 bis 7 hergestellten antimikrobiellen Polymeren zur Herstellung von Erzeugnissen mit einer antimikrobiellen Beschichtung aus dem Polymer.8. Use of the antimicrobial polymers produced according to one of claims 1 to 7 for the production of products with an antimicrobial coating from the polymer.
9. Verwendung der nach einem der Ansprüche 1 bis 7 hergestellten antimikrobiellen Polymeren zur Herstellung von medizintechnischen Artikeln mit einer antimikrobiellen Beschichtung aus dem Polymer.9. Use of the antimicrobial polymers produced according to one of claims 1 to 7 for the production of medical articles with an antimicrobial coating from the polymer.
10. Verwendung der nach einem der Ansprüche 1 bis 7 hergestellten antimikrobiellen Polymeren zur Herstellung von Hygieneartikeln mit einer antimikrobiellen Beschichtung aus dem Polymer.10. Use of the antimicrobial polymers produced according to one of claims 1 to 7 for the production of hygiene articles with an antimicrobial coating made of the polymer.
11. Verwendung der nach einem der Ansprüche 1 bis 7 hergestellten antimikrobiellen Polymeren in Lacken, Schutzanstrichen oder Beschichtungen. 11. Use of the antimicrobial polymers produced according to one of claims 1 to 7 in lacquers, protective coatings or coatings.
PCT/EP2000/002783 1999-05-12 2000-03-30 Method of producing inherently microbicidal polymer surfaces WO2000069925A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU72362/00A AU7236200A (en) 1999-05-12 2000-03-30 Method of producing inherently microbicidal polymer surfaces
EP00922570A EP1183282A1 (en) 1999-05-12 2000-03-30 Method of producing inherently microbicidal polymer surfaces

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19921898.6 1999-05-12
DE19921898A DE19921898A1 (en) 1999-05-12 1999-05-12 Preparation of antimicrobial polymer for medical and hygiene articles, varnishes, paints and coatings comprises polymerizing monomers that have been functionalized by a tert. amino group

Publications (1)

Publication Number Publication Date
WO2000069925A1 true WO2000069925A1 (en) 2000-11-23

Family

ID=7907833

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/002783 WO2000069925A1 (en) 1999-05-12 2000-03-30 Method of producing inherently microbicidal polymer surfaces

Country Status (4)

Country Link
EP (1) EP1183282A1 (en)
AU (1) AU7236200A (en)
DE (1) DE19921898A1 (en)
WO (1) WO2000069925A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080674A1 (en) * 2001-04-06 2002-10-17 Creavis Gesellschaft Für Technologie Und Innovation Mbh Antimicrobial preservation systems for foodstuffs
US8282959B2 (en) 2006-11-27 2012-10-09 Actamax Surgical Materials, Llc Branched end reactants and polymeric hydrogel tissue adhesives therefrom
US8426492B2 (en) 2007-11-14 2013-04-23 Actamax Surgical Materials, Llc Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8431114B2 (en) 2004-10-07 2013-04-30 Actamax Surgical Materials, Llc Polysaccharide-based polymer tissue adhesive for medical use
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8580951B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
US8951989B2 (en) 2009-04-09 2015-02-10 Actamax Surgical Materials, Llc Hydrogel tissue adhesive having reduced degradation time
US9044529B2 (en) 2008-11-19 2015-06-02 Actamax Surgical Materials, Llc Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US10207021B2 (en) 2013-07-29 2019-02-19 Actamax Surgical Materials, Llc Low sweel tissue adhesive and sealant formulations

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10062201A1 (en) * 2000-12-13 2002-06-20 Creavis Tech & Innovation Gmbh Process for the use of antimicrobial polymers in building and monument protection
DE10110885A1 (en) * 2001-03-07 2002-09-12 Creavis Tech & Innovation Gmbh Mocrobicidal separation systems
DE102008005875A1 (en) 2008-01-24 2009-07-30 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Use of polymers with amino or ammonium groups to increase the durability of wood over woody fungi

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB973294A (en) * 1961-01-30 1964-10-21 Morton Salt Co Polymer finishing composition
GB1008465A (en) * 1960-12-07 1965-10-27 Rohm & Haas Coating compositions
GB1195615A (en) * 1967-07-14 1970-06-17 Celanese Corp Treatment of Materials and Articles made from Polyesters
EP0862859A1 (en) * 1997-03-06 1998-09-09 Hüls Aktiengesellschaft Process for preparing antimicrobial plastics
EP0872512A2 (en) * 1997-04-14 1998-10-21 Hüls Aktiengesellschaft Process for modifying the surface of polymeric substrates by graft polymerisation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1008465A (en) * 1960-12-07 1965-10-27 Rohm & Haas Coating compositions
GB973294A (en) * 1961-01-30 1964-10-21 Morton Salt Co Polymer finishing composition
GB1195615A (en) * 1967-07-14 1970-06-17 Celanese Corp Treatment of Materials and Articles made from Polyesters
EP0862859A1 (en) * 1997-03-06 1998-09-09 Hüls Aktiengesellschaft Process for preparing antimicrobial plastics
EP0872512A2 (en) * 1997-04-14 1998-10-21 Hüls Aktiengesellschaft Process for modifying the surface of polymeric substrates by graft polymerisation

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080674A1 (en) * 2001-04-06 2002-10-17 Creavis Gesellschaft Für Technologie Und Innovation Mbh Antimicrobial preservation systems for foodstuffs
US8431114B2 (en) 2004-10-07 2013-04-30 Actamax Surgical Materials, Llc Polysaccharide-based polymer tissue adhesive for medical use
US8282959B2 (en) 2006-11-27 2012-10-09 Actamax Surgical Materials, Llc Branched end reactants and polymeric hydrogel tissue adhesives therefrom
US8426492B2 (en) 2007-11-14 2013-04-23 Actamax Surgical Materials, Llc Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
US9044529B2 (en) 2008-11-19 2015-06-02 Actamax Surgical Materials, Llc Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US8951989B2 (en) 2009-04-09 2015-02-10 Actamax Surgical Materials, Llc Hydrogel tissue adhesive having reduced degradation time
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8580951B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
US10207021B2 (en) 2013-07-29 2019-02-19 Actamax Surgical Materials, Llc Low sweel tissue adhesive and sealant formulations

Also Published As

Publication number Publication date
AU7236200A (en) 2000-12-05
DE19921898A1 (en) 2000-11-16
EP1183282A1 (en) 2002-03-06

Similar Documents

Publication Publication Date Title
EP0862858B1 (en) Process for preparing antimicrobial plastics
EP1183281A1 (en) Method for producing inherently microbicidal polymer surfaces
EP1183282A1 (en) Method of producing inherently microbicidal polymer surfaces
WO2001085813A2 (en) Antimicrobial, aminofunctionalised copolymers
WO2001072859A1 (en) Microbicidal coatings containing acrylo-substituted alkylsulphonic acid polymers
WO2000069933A1 (en) Method for producing inherently microbicidal polymer surfaces
WO2001016193A1 (en) Copolymers of acryloyloxyalkylamino compounds
WO2001019878A1 (en) Copolymers of acryloylaminoalkyl compounds
DE10024270A1 (en) Antimicrobial polymer production, comprises polymerizing optionally substituted acrylamide monomers, used e.g. for coating medical and hygiene articles
EP1214366A1 (en) Copolymers of aminopropyl vinyl ether
EP1183291A1 (en) Antimicrobial copolymers
EP1183292A1 (en) Microbicidal copolymers
WO2000069934A1 (en) Microbicidal copolymers
WO2001062810A1 (en) Copolymers of allylphosphonium salts
WO2000069935A1 (en) Method for producing inherently microbicidal polymer surfaces
WO2000069937A1 (en) Microbicidal copolymers
DE19940697A1 (en) Antimicrobial copolymer, used for food packaging, cosmetics, nappies and contact lenses, is prepared by copolymerization of vinylether ammonium salt with aliphatic unsaturated monomer
DE19952222A1 (en) Preparation of antimicrobial copolymer used for hygiene articles and in paints, by copolymerizing ethylamino alkyl amide(s) and aliphatically unsaturated comonomer(s)
DE19943344A1 (en) Antimicrobial copolymer of permanently antimicrobial surface obtained by graft copolymerization of an alkylaminoalkylamide with an unsaturated monomer useful for medical and hygiene items
DE19955992A1 (en) Intrinsically anti-microbial copolymer, used e.g. as an in situ-produced coating on medical articles, is based on acryloyloxyalkylamino compound such as 2-dimethylaminoethyl methacrylate
DE10242561A1 (en) Antimicrobial coating, useful for the production of products with antimicrobial properties, preferably medical or hygiene articles, comprises polymers of cyclic amines having at least one polymerizable unsaturated group
DE10123195A1 (en) Elution-free antimicrobial polymers
DE19952221A1 (en) Intrinsically anti-microbial copolymer, used e.g. as an in situ-produced coating on medical articles, is based on acryloyloxyalkylamino compound such as 2-dimethylaminoethyl methacrylate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN IL JP KR NO NZ PL RU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2000922570

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09926470

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000922570

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000922570

Country of ref document: EP